Yoonkyu Lee, MS, BS^1,2,3, Wen Wang, PhD^4*, Timothy K Starr, PhD^1,5*, Klara E Noble-Orcutt, BS, MS^1,3*, Chad L Myers, PhD^2,4* and Zohar Sachs, MD, PhD^1,2,3

¹Masonic Cancer Center, University of Minnesota, Minneapolis, MN
²Bioinformatics and Computational Biology Program, University of Minnesota, Minneapolis, MN
³Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
⁴Department of Computer Science and Engineering, University of Minnesota, Minneapolis, MN
⁵Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, MN

Bin Lu^1*, Pu Zhang^1*, Sisi Chen^2*, Salima Benbarche, PhD^3*, Cynthia Castro^1*, Nina Fox^1*, Mohammad Abubakar¹, Jeetayu Biswas^1*, Ruslan Soldatov^1*, Richard Koche, PhD^4* and Omar Abdel-Wahab, MD⁵

¹Memorial Sloan Kettering Cancer Center, New York
²Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY

Christian Bahne Thygesen, PhD^1*, Michael Schantz Klausen, PhD^1*, Nikolas Thuesen, Msc^1*, Christian Garde, PhD^1*, Anders Jespersen, MD, PhD^2*, Kirsten Grønbæk, MD, DMSc^3,4, Jens Kringelum, PhD^1* and Anders Bundgård Sorensen, PhD, MBA^1*

¹Evaxion Biotech, Hørsholm, Denmark
²Evaxion Biotech, Horsholm, Denmark
³Biotech Research and Innovation Centre, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
⁴Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Mike Mattie, PhD^1*, Marc Gillard^2*, Monica Calderon^2*, Sophia Do^2*, Shruti Salunkhe^1*, Darren Heeke^1*, Jose Morachis, PhD^3*, Benjamin Titz, PhD^3* and Chorom Pak, PhD^2*

¹Kite Pharma, a Gilead company, Santa Monica, CA
²Lynx Biosciences, San Diego, CA
³Lynx Biosciences, Inc., San Diego, CA

Jurik A Mutter, PhD^1*, Mohammad Shahrokh Esfahani, PhD^1*, Joseph G Schroers-Martin, MD¹, Stefan K. Alig, MD², Mark P. Hamilton, MD³, Brian J. Sworder, MD, PhD⁴, Benoit Tessoulin^5,6*, Jan Boegeholz, MD⁷, Timothy Flerlage, MD^8*, Jamie E. Flerlage, MD, MS⁹, Michael S. Binkley, MD, MS^10*, Takeshi Sugio, MD, PhD^11*, Cédric Rossi, MD, PhD^12,13, Mari Olsen^1*, Chih Long Liu^1*, Steven Le Gouill, MD, PhD¹⁴, David M. Kurtz, MD, PhD¹, Maximilian Diehn, MD, PhD^15* and Ash A. Alizadeh, MD, PhD¹

¹Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
²Divisions of Oncology and Hematology, Stanford University School of Medicine, Stanford, CA
³Division of Hematology and Oncology, Stanford University, Palo Alto, CA
⁴Division of Oncology, Department of Medicine, Stanford University, Irvine, CA
⁵Hematology Department, CHU Nantes, Nantes, France
⁶CRCNA, INSERM CNRS, Nantes, France
⁷Divisions of Hematology and Oncology, Stanford University, Stanford, CA
⁸Department of Oncology, St Jude Children's Research Hospital, Memphis, TN
⁹Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
¹⁰Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
¹¹Divisions of Oncology and Hematology, Stanford University, Washington, MD
¹²Stanford University, Stanford, CA
¹³CHU Dijon, Dijon, France
¹⁴Hematology Department, Institut Curie, Paris, France
¹⁵Department of Radiation Oncology, Stanford University, Stanford, CA

Arda Durmaz, PhD^1*, Carmelo Gurnari, MD^2*, Simona Pagliuca, MD, PhD^3,4, Colin Hercus^5*, Carlos Bravo-Perez, MD^2,6*, Luca Guarnera, MD^2,7*, Nakisha D Williams, MBBS^2*, Danai Dima, MD², Ishani Nautiyal, BS^2*, Yasuo Kubota, MD, PhD^2*, Naomi Kawashima, MD, PhD^2*, Jacob Scott^2*, Valeria Visconte, PhD² and Jaroslaw P. Maciejewski, M.D., Ph.D., FACP²

¹Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, CLEVELAND, OH
²Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
³Department of Hematology, Centre Hospitalier Régional Universitaire (CHRU), Vandœuvre-lès-Nancy, France, France
⁴Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH
⁵Novocraft Technologies Sdn Bhd, Kuala Lumpur, Malaysia
⁶Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, University of Murcia, IMIB-Pascual Parrilla, CIBERER - Instituto de Salud Carlos III, Murcia, Spain
⁷Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy